Free Trial

Renaissance Technologies LLC Sells 12,545 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU)

Kewaunee Scientific logo with Computer and Technology background

Renaissance Technologies LLC cut its position in shares of Kewaunee Scientific Co. (NASDAQ:KEQU - Free Report) by 10.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 104,566 shares of the technology company's stock after selling 12,545 shares during the quarter. Renaissance Technologies LLC owned 3.64% of Kewaunee Scientific worth $6,469,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Geode Capital Management LLC boosted its position in Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after purchasing an additional 1,941 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock worth $30,000 after buying an additional 900 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in Kewaunee Scientific in the fourth quarter valued at $338,000. Barclays PLC bought a new position in shares of Kewaunee Scientific in the 3rd quarter valued at about $121,000. Finally, Truffle Hound Capital LLC acquired a new position in shares of Kewaunee Scientific during the 4th quarter worth about $619,000. Institutional investors own 32.69% of the company's stock.

Insiders Place Their Bets

In other Kewaunee Scientific news, CEO Thomas David Hull III sold 3,000 shares of Kewaunee Scientific stock in a transaction on Monday, March 24th. The stock was sold at an average price of $45.63, for a total value of $136,890.00. Following the completion of the transaction, the chief executive officer now directly owns 37,916 shares of the company's stock, valued at $1,730,107.08. The trade was a 7.33 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Keith M. Gehl acquired 1,000 shares of the business's stock in a transaction that occurred on Friday, April 4th. The shares were purchased at an average cost of $35.00 per share, with a total value of $35,000.00. Following the transaction, the director now directly owns 18,500 shares of the company's stock, valued at $647,500. This trade represents a 5.71 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 11,057 shares of company stock worth $440,326 in the last 90 days. Company insiders own 14.20% of the company's stock.

Kewaunee Scientific Stock Performance

Shares of NASDAQ KEQU traded down $0.32 during mid-day trading on Thursday, reaching $33.62. 2,003 shares of the company were exchanged, compared to its average volume of 24,995. The stock has a market capitalization of $95.99 million, a P/E ratio of 5.33 and a beta of 0.59. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. The company's 50-day simple moving average is $44.45 and its 200-day simple moving average is $47.29. Kewaunee Scientific Co. has a twelve month low of $30.82 and a twelve month high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The company had revenue of $67.17 million during the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Analyst Ratings Changes

Separately, StockNews.com cut Kewaunee Scientific from a "buy" rating to a "hold" rating in a report on Friday, March 14th.

Check Out Our Latest Analysis on KEQU

Kewaunee Scientific Company Profile

(Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Featured Stories

Institutional Ownership by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

Should You Invest $1,000 in Kewaunee Scientific Right Now?

Before you consider Kewaunee Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.

While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines